Pharmacokinetic properties of huperzine A sustained release tablets in dogs
Zhimin Wu
Abstract
Zhimin Wu
Abstract
Objective:To study the pharmaeokinetic properties of huperzine A sustained release tablets (test tablets)in dogs with immediate release tablets as the reference.Methods:The test(2 tablets)and reference tablets(4 tablets)of huperzine A(200μg)were administered to six dogs by a two-period cross design method. The HPLC method was applied to determine plasma huperzine A.Non-compartment model method was used to cal- culate the pharmacokinetic parameters.Results:T_(max)of huperzine A for the test and reference tablets was(9.33±1.63)and(3.00±0.92)h,respectively;t_(1/2)was(11.01±2.66)and(4.71±1.00)h;C_(max)was(1.95±0.29)and(6.23±0.91)ng·mL~(-1);AUC_(0~t)was(28.29±2.03)and(27.45±1.83)ng·h·mL~(-1).The relative bioavailability of huperzine A sustained release tablets was(103.06±3.72)%.Conclusion:Huperzine A sus- tained release tablets shows characteristics of slow release,and the two preparations were bioequivalent according to statistical analysis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the pharmaeokinetic properties of huperzine A sustained release tablets (test tablets)in dogs with immediate release tablets as the reference.Methods:The test(2 tablets)and reference tablets(4 tablets)of huperzine A(200μg)were administered to six dogs by a two-period cross design method. The HPLC method was applied to determine plasma huperzine A.Non-compartment model method was used to cal- culate the pharmacokinetic parameters.Results:T_(max)of huperzine A for the test and reference tablets was(9.33±1.63)and(3.00±0.92)h,respectively;t_(1/2)was(11.01±2.66)and(4.71±1.00)h;C_(max)was(1.95±0.29)and(6.23±0.91)ng·mL~(-1);AUC_(0~t)was(28.29±2.03)and(27.45±1.83)ng·h·mL~(-1).The relative bioavailability of huperzine A sustained release tablets was(103.06±3.72)%.Conclusion:Huperzine A sus- tained release tablets shows characteristics of slow release,and the two preparations were bioequivalent according to statistical analysis.
Key concepts: Huperzine A, Bioequivalence, Bioavailability, Immediate release, Pharmacokinetics, Chemistry, Chromatography, Pharmacology